Understanding cancer risk and outcomes in African Americans
Official title: Admin Core
Funded at Wayne State University · NIH-11034096 · Data updated 2026-11-12
This study is looking at how genes affect cancer risk and outcomes in African Americans, with the goal of sharing helpful information and support for cancer survivors and their families.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wayne State University NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project start | February 13, 2024 |
| Project end | January 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $144,664 |
| NIH project number | 5P01CA272239-02 |
| Project ID | NIH-11034096 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include African American individuals who are at risk for or have been diagnosed with cancer.
✕Less likely to help
Patients outside the African American demographic or those without a cancer diagnosis may not receive direct benefits from this research.
What this research studies
This research focuses on the genetic factors that influence cancer risk and outcomes specifically in the African American population. It involves coordinating various research projects and resources to gather data and insights on cancer genetics, aiming to improve understanding and communication about cancer risks. The program will also facilitate collaboration among researchers, healthcare providers, and the community to ensure effective dissemination of findings and support for cancer survivors. By integrating leadership and oversight, the research aims to enhance the effectiveness of cancer-related initiatives.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer risk assessment and tailored treatment options for African American patients.
How similar studies have gone: Previous research has shown success in understanding cancer disparities through genetic studies, making this approach both relevant and promising.
Where this research is happening
-
Wayne State University
Detroit, United States Active
Researchers
- Principal investigator: Schwartz, Ann G. — Wayne State University
- Study coordinator: Schwartz, Ann G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.